Insider · CIK 0002074003
Skaff Michael C
Reports to the SEC for 1 company · GROSSE POINTE, MI
Transactions
8
Companies
1
Filings
2
CIK
0002074003
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-30 | VVOSVivos Therapeutics, Inc. · Series A Convertible Preferred StockP Purchase | +$500K |
| 2026-06-30 | VVOSVivos Therapeutics, Inc. · Series A Convertible Preferred StockP Purchase | +$1.1M |
| 2026-06-30 | VVOSVivos Therapeutics, Inc. · Common Stock Purchase WarrantP Purchase | +$1.6M |
| 2026-03-31 | VVOSVivos Therapeutics, Inc.P Purchase | +$1.4M |
| 2026-03-31 | VVOSVivos Therapeutics, Inc.P Purchase | +$414K |
| 2026-03-31 | VVOSVivos Therapeutics, Inc. · Pre-Funded WarrantP Purchase | +$576K |
| 2026-03-31 | VVOSVivos Therapeutics, Inc. · Series A Common Stock WarrantP Purchase | +$2.39M |
| 2026-03-31 | VVOSVivos Therapeutics, Inc. · Series B Common Stock WarrantP Purchase | +$2.39M |
Recent filings
- 4Skaff Michael C0001193125-26-304815SEC(opens sec.gov)
- 4Skaff Michael C0002074003-26-000008SEC(opens sec.gov)
Companies
Address
18000 MACK AVE
GROSSE POINTE, MI, 48230